Mutated lamin A modulates stiffness in muscle cells

Area of Science:

• Cell Biology
• Biophysics
• Mechanobiology

Background:

• The cytoskeleton, composed of actin filaments, microtubules, and intermediate filaments, provides mechanical support and force generation in cells.
• Nuclear A-type lamins connect to the cytoskeleton via the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex.
• The exact role of intermediate filament proteins, including A-type lamins, in cellular mechanical properties is not fully understood.

Purpose of the Study:

• To investigate the impact of a specific A-type lamin mutation (p.H222P) on the mechanical properties of muscle cells.
• To explore the relationship between A-type lamins, cellular mechanics, and mechano-signaling pathways.

Main Methods:

• Micro-constriction rheology was employed to measure the mechanical properties of muscle cells.
• Cell biology techniques were used to assess cellular responses and molecular interactions.
• The effect of selumetinib, an ERK1/2 signaling inhibitor, on mutated cells was evaluated.

Main Results:

• Muscle cells expressing the p.H222P mutation of lamin A exhibited increased cellular stiffness compared to cells with wild-type lamin A.
• Treatment with selumetinib reversed the increased cellular stiffness observed in mutated cells.
• These findings indicate a significant interplay between A-type lamins and mechano-signaling.

Conclusions:

• A-type lamins play a crucial role in determining the mechanical properties of muscle cells.
• The p.H222P mutation in lamin A alters cellular stiffness through mechanisms involving mechano-signaling pathways.
• Targeting mechano-signaling pathways, such as ERK1/2, may offer therapeutic potential for conditions associated with laminopathies.